Biological aging sped up during chemotherapy — and only the lifting group stopped the acceleration

Claims that lifting is good for you usually get proved with visible measures — muscle mass, strength, function. This study looked a layer down: at biological age measured through DNA methylation, how fast it moved during chemotherapy, and whether resistance training slowed it.

The participants were adults with stage II–III colon cancer in the FORCE randomised trial, assigned during adjuvant chemotherapy to either usual care or resistance training. Blood DNA methylation was measured at baseline and follow-up to derive several epigenetic clocks including DNAmPhenoAge, GrimAge and DunedinPACE, with body composition and physical function tracked alongside.

What an epigenetic clock actually measures

Calendar age runs at the same rate for everyone. Epigenetic clocks estimate biological age from DNA methylation patterns, so two people at 40 can read very differently. DunedinPACE captures the rate at which aging is proceeding; GrimAge captures cumulative aging tied to mortality risk. They are not the same measure, and they did not move together here.

How much aging happened in six months

The largest movement was in DunedinPACE acceleration at 0.70 SD per six months (95% CI 0.41–0.98), followed by GrimAge acceleration at 0.29 SD per six months (95% CI 0.13–0.46) — which the authors convert to approximately 1.2 years. Half a year of treatment, more than a year of aging.

Baseline carried a signal too: higher DunedinPACE acceleration went with greater adiposity and poorer physical function. A fast aging rate and an already-weakened body travelled together.

The training group's acceleration stalled

The central result appears once the arms are separated. Usual care participants showed significant GrimAge acceleration at 0.45 SD per six months (95% CI 0.24–0.60). In the resistance training group there was no significant acceleration.

Read that precisely. Resistance training did not reverse aging; it held down the acceleration treatment was pushing. The authors' word is attenuate, not reduce.

A change body composition could not see

The most interesting finding is a negative one. Changes in epigenetic age acceleration were not strongly associated with changes in body composition or physical function. The authors read this as DNA methylation measures capturing treatment-period physiologic change that body composition and function testing do not fully reflect.

Which means body weight can hold steady and a strength test can read the same while a clock inside runs differently. There is a layer that logging loads and reps does not reach.

What a lifter takes from this

What this suggests for healthy people is conditional, but the direction is clear: through periods of heavy physiological stress, resistance training works by slowing what you lose. Chemotherapy is an extreme case, but a large cut, recovery from surgery, or a stretch of overwork sit in the same category at lower intensity. In those windows the goal of training is not a new record — it is holding the acceleration down.

One more point for tracking. Body composition and physical function failed to reflect what was happening underneath. Weight and appearance staying the same guarantees nothing. A Muscle Index built from Big 3 1RMs is not a complete instrument either, but it is at least a number you can re-measure under the same conditions — a better baseline than the scale for seeing whether you are holding or slipping through a hard stretch. How much lifting protects muscle in a deficit is in lifting through a severe deficit, and age-adjusted programming in training hard after 50.